Since the coumarin system is found in the composition of many natural compounds, derivatives of coumarin have excited considerable interest. On this basis medicinal preparations have been obtained and developed with a wide range of biological activities, in particular Psoralen, Angelicin, Xanthotoxin, Bergapten, and Nodakenetin. These preparations contain a furane ring in their structures and they are used for treatment of human psoriasis, eczema, and leisure of skin pigmentation.Furocoumarins are also used for the treatment of some types of cancer, for example cellular T-lymphoma [1-3]. The basic drawback of furocoumarins is their high phototoxicity. On the other hand, the synthesis and investigation of a series of organic and inorganic selenium compounds in many cases revealed a wide spectrum of biological activity, in particular selenium-containing derivatives showed the possibility of their use in the treatment of malignant tumors [4][5][6].With the objective of producing new potentially biologically active heterocyclic systems we have developed a preparative method for the synthesis of the methyl ester of 3-bromo-2-(2-hydroxy-2-propyl)-7-oxo-7H-selenolo[2,3-f]chromene-8-carboxylic acid -a new example of a class of selenophene-containing polycyclic heterocycles. The methyl ester of 6-(3-hydroxy-3-methylbutyn-1-yl)coumarin-3-carboxylic acid (2) was obtained in satisfactory yield as a result of the interaction of the starting coumarin 1 with 3-hydroxy-3-methylbutyne in the presence of bis(triphenylphosphino)palladium dichloride and copper(I) iodide. The reaction was carried out in a mixture of DMF and diisopropylamine at 80° and monitored by TLC. Then a solution of coumarin 2 in dioxane was slowly added dropwise to a solution of selenium(IV) tetrabromide in hydrogen bromide prepared in situ. As a result SeBr 4 added to the triple bond to give the intermediate 3.